Contact: Bill Schaller
Dana-Farber Cancer Institute
Caption: Peter Sicinski, M.D., Ph.D., and colleagues at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins that control cells' growth cycles, and to which the cancers are "addicted."
Credit: Sam Ogden
Usage Restrictions: None
Related news release: Targeting cancers' 'addiction' to cell-cycle proteins shuts down tumors in mice